Evidence map›Paper›PMID 26871576›Full record

ArticlePloS one2016

Lipid Droplet Formation, Their Localization and Dynamics during Leishmania major Macrophage Infection.

Sameh Rabhi, Imen Rabhi, Bernadette Trentin, David Piquemal, Béatrice Regnault, Sophie Goyard, Thierry Lang, Albert Descoteaux, Jost Enninga, Lamia Guizani-Tabbane

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2026
    Review
  3. Article
  4. Interaction BetweenMicroorganisms · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Perilipin1 inhibitsMicrobiology spectrum · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Fatty Acid Composition and Metabolism inInternational journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Major Molecular Factors Related toFrontiers in immunology · 2022
    Review
  19. Review
  20. Lipid and fatty acid metabolism in trypanosomatids.Microbial cell (Graz, Austria) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Sameh RabhiInstitut Pasteur de Tunis, Laboratoire de Parasitologies médicales biotechnologies et Biomolecules, University of Tunis El Manar, 13, Place Pasteur - B. P. 74, 1002, Tunis-Belvedere, Tunisia.
Imen RabhiInstitut Pasteur de Tunis, Laboratoire de Parasitologies médicales biotechnologies et Biomolecules, University of Tunis El Manar, 13, Place Pasteur - B. P. 74, 1002, Tunis-Belvedere, Tunisia.
Bernadette TrentinAcobiom Cap Delta-Biopôle Euromédecine II. 1682, rue de la Valsière - 34184, Montpellier, Cedex 4, France.
David PiquemalAcobiom Cap Delta-Biopôle Euromédecine II. 1682, rue de la Valsière - 34184, Montpellier, Cedex 4, France.
Béatrice RegnaultDNA Chip Platform, Genopole, Institut Pasteur de Paris, 25-28 rue du Dr Roux, 75015, Paris, France.
Sophie GoyardInstitut Pasteur, Département Infection et Epidémiologie, Laboratoire des Processus infectieux à Trypanosomatidés, 26 rue du Dr Roux, 75724, Paris, Cedex 15, France.
Thierry LangInstitut Pasteur, Département Infection et Epidémiologie, Laboratoire des Processus infectieux à Trypanosomatidés, 26 rue du Dr Roux, 75724, Paris, Cedex 15, France.
Albert DescoteauxINRS-Institut Armand Frappier and Centre for Host-Parasite Interactions, 531, boulevard des Prairies, Laval (Québec), H7V 1B7, Canada.
Jost EnningaInstitut Pasteur, Dynamics of host-pathogen interactions Unit, 25 Rue du Dr. Roux, 75724, Paris, France.
Lamia Guizani-TabbaneInstitut Pasteur de Tunis, Laboratoire de Parasitologies médicales biotechnologies et Biomolecules, University of Tunis El Manar, 13, Place Pasteur - B. P. 74, 1002, Tunis-Belvedere, Tunisia.
Institut Pasteur · FRAcobiom (France) · FRInstitut National de la Recherche Scientifique · CAMaterials Resources (United States) · USTunis El Manar University · TNUniversity of Carthage · TN

Funding

Canadian Institutes of Health Research MOP-12933
6 · The paper itself

Abstract

Leishmania, the causative agent of vector-borne diseases, known as leishmaniases, is an obligate intracellular parasite within mammalian hosts. The outcome of infection depends largely on the activation status of macrophages, the first line of mammalian defense and the major target cells for parasite replication. Understanding the strategies developed by the parasite to circumvent macrophage defense mechanisms and to survive within those cells help defining novel therapeutic approaches for leishmaniasis. We previously showed the formation of lipid droplets (LDs) in L. major infected macrophages. Here, we provide novel insights on the origin of the formed LDs by determining their cellular distribution and to what extent these high-energy sources are directed to the proximity of Leishmania parasites. We show that the ability of L. major to trigger macrophage LD accumulation is independent of parasite viability and uptake and can also be observed in non-infected cells through paracrine stimuli suggesting that LD formation is from cellular origin. The accumulation of LDs is demonstrated using confocal microscopy and live-cell imagin in parasite-free cytoplasmic region of the host cell, but also promptly recruited to the proximity of Leishmania parasites. Indeed LDs are observed inside parasitophorous vacuole and in parasite cytoplasm suggesting that Leishmania parasites besides producing their own LDs, may take advantage of these high energy sources. Otherwise, these LDs may help cells defending against parasitic infection. These metabolic changes, rising as common features during the last years, occur in host cells infected by a large number of pathogens and seem to play an important role in pathogenesis. Understanding how Leishmania parasites and different pathogens exploit this LD accumulation will help us define the common mechanism used by these different pathogens to manipulate and/or take advantage of this high-energy source.

Indexed as

AnimalsCells, CulturedHost-Parasite InteractionsHumansLeishmania majorLeishmaniasis, CutaneousLipid DropletsLipid MetabolismMacrophagesMice, Inbred BALB CProstaglandinsTranscriptomeProstaglandins

Identifiers

PMID26871576
PMCPMC4752496
OpenAlexW2288165580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.